ArticleCureus2026
Mastering Transabdominal Preperitoneal (TAPP): A 5,124 Case Journey in Hernia Repair With a Singular Approach and Our Results.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Inguinal hernia is a common surgical condition resulting from a defect in the myofascial plane, with both congenital and acquired etiologies. Although open repair has traditionally been the standard approach, over the last decade, laparoscopic repair, particularly the transabdominal preperitoneal (TAPP) method, has gained popularity due to its diagnostic and therapeutic advantages. However, its adoption has been limited due to technical complexity and perceived complication risks. Objective To present our technique, perioperative strategy, and outcomes in a large cohort of patients undergoing laparoscopic TAPP hernia repair, with a focus on refining surgical steps to optimize safety and efficacy. Methods A retrospective review was conducted on laparoscopic TAPP hernia repairs performed on 5,124 patients over a defined period. Institutional ethical approval was obtained. Preoperative assessments included dynamic imaging and individual risk stratification. Surgical technique emphasized wide preperitoneal dissection, tailored mesh placement with at least 3 cm overlap, and meticulous closure of peritoneal flaps. A four-port approach was used, and a variety of groin hernias (inguinal, femoral, and obturator) were included. Concurrent umbilical and Spigelian hernias were repaired when encountered. Results Of the 5,124 patients, 4,252 were males (83%), and 872 were females (17%). The technique proved feasible across a broad body mass index (BMI) spectrum (19-46) and in patients with prior abdominal surgery. Complications were minimal, conversion to open surgery occurred in 13 patients (0.25%) of cases, and recurrence rates were low (less than 0.3%). 153 patients (3%) developed seroma/hematoma formation, whereas 256 patients (5%) developed urinary retention postoperatively. The tailored use of overlapping mesh segments and cautious dissection minimized the risk of recurrence and postoperative complications such as seroma or chronic pain. Conclusion Our experience with laparoscopic TAPP repair suggests that, when performed by an experienced surgeon using a standardized technique and with careful attention to anatomical detail, this approach can be safe and effective. When utilised by an experienced surgeon, TAPP enables comprehensive groin assessment, supports early recovery, and can deliver durable repair outcomes, including in more complex cases. With appropriate training, these findings support the continued and considered adoption of the TAPP approach in hernia surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.